EUVIMEDEUVIMED entdecken
Crossref

Advanced Strategies for Remimazolam Application

Kotoe KAMATA

THE JOURNAL OF JAPAN SOCIETY FOR CLINICAL ANESTHESIA · 15.11.2025 · 45 (6) · 601-607

DOI: 10.2199/jjsca.45.601 ↗

Kurz gefasst

Fachartikel in der Zeitschrift THE JOURNAL OF JAPAN SOCIETY FOR CLINICAL ANESTHESIA, erschienen am 15.11.2025. Verfasst von Kotoe KAMATA.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Remimazolam besylate, an ultra-short-acting benzodiazepine, has become familiar in our clinical practice. Its pharmacological properties of short duration and having a specific antagonist are considerable advantages, especially in cases where delayed emergence is a concern. However, its short-acting property also poses a risk:inappropriate dosing adjustments may lead to intraoperative awareness. Therefore, safe and effective anesthesia with remimazolam requires the ability to accurately assess its sedative effect. This article discusses advanced strategies for anesthetic management utilizing the unique pharmacokinetic and pharmacodynamic characteristics of remimazolam, based on the author’s personal experience and a review of the current literature.

Zitieren

APA

KAMATA, K. (2025). Advanced Strategies for Remimazolam Application. THE JOURNAL OF JAPAN SOCIETY FOR CLINICAL ANESTHESIA, 45(6), 601-607. https://doi.org/10.2199/jjsca.45.601

Vancouver

KAMATA K. Advanced Strategies for Remimazolam Application. THE JOURNAL OF JAPAN SOCIETY FOR CLINICAL ANESTHESIA. 2025;45(6):601-607. doi:10.2199/jjsca.45.601

BibTeX
@article{KAMATA2025,
  author = {KAMATA, Kotoe},
  title = {Advanced Strategies for Remimazolam Application},
  journal = {THE JOURNAL OF JAPAN SOCIETY FOR CLINICAL ANESTHESIA},
  year = {2025},
  volume = {45},
  number = {6},
  pages = {601--607},
  doi = {10.2199/jjsca.45.601}
}
Kostenlos starten →